Q2 2025 · 13F-HR
Lepercq De Neuflize Asset Management LLCholdings as filed
Filed 2025-08-11 · accession 0001420506-25-001824
$151.6M
Reported value
10
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $71.2M | 47.0% | 115,245 | Common | SOLE |
| 464287465 | EFA | ISHARES TR | $41.7M | 27.5% | 466,000 | Common | SOLE |
| 78462F953 | — | SPDR S&P 500 ETF TR | $37.1M | 24.5% | 60,000 | PUT | SOLE |
| 74736K101 | QRVO | QORVO INC | $1.2M | 0.77% | 13,700 | Common | SOLE |
| 58471G508 | MDGSUSD | XYLO TECHNOLOGIES LTD | $132,385 | 0.09% | 26,059 | Common | SOLE |
| 18270P109 | CLAR | CLARUS CORP NEW | $111,734 | 0.07% | 32,200 | Common | SOLE |
| 74102L501 | SQFT | PRESIDIO PPTY TR INC | $75,375 | 0.05% | 14,412 | Common | SOLE |
| 961881208 | WETH | WETOUCH TECHNOLOGY INC | $74,041 | 0.05% | 77,954 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $57,290 | 0.04% | 33,700 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $40,920 | 0.03% | 31,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.